VFA
DOVA

Virtus Fund Advisers’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Virtus Fund Advisers’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$318K Buy
+11,044
New +$303K ﹤0.01% 444

Other funds holding DOVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Virtus Fund Advisers's DOVA Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2017: 11,044 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #444 among its holdings.

48 funds tracked by Wall St. Rank hold DOVA as of Q4 2017.

  • Virtus Fund Advisers held 11,044 shares of Dova Pharmaceuticals, Inc. Common Stock worth $318K as of Q4 2017.
  • Dova Pharmaceuticals, Inc. Common Stock was a new Virtus Fund Advisers position in Q4 2017.
  • Dova Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #444 holding.
  • 48 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.